RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Chordoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Physaliferous Puzzle: A Tale of a Unique Histopathological Landscape in Chordoma
Aprajita Garg et al., Journal of the Indian Medical Association (14 October 2026)
https://doi.org/10.5005/jima-11070-0137
- 2.
Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study.
Du Xinhui et al., International orthopaedics (12 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42860435/
- 3.
An institutional review of clinical outcomes for skull base chordoma: an analysis of 269 cases over 19 years.
Muthiah Nallammai et al., Journal of neurosurgery (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42398106/
- 4.
The molecular landscape of chordoma: Current frontiers from multi-omics to artificial intelligence.
Tecimel Didem et al., Biochimica et biophysica acta. Reviews on cancer (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42571860/
- 5.
Cervical spine chordoma: Imaging features and diagnostic challenges of a rare C6 localization.
El Kadiri Salma et al., Radiology case reports (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42598210/
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801 · Active (not recruiting) · Phase 1 / Phase 2 · National Cancer Institute (NCI)
Ages 12 Months and over
https://clinicaltrials.gov/study/NCT05286801
- 2.
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma
NCT02601950 · Completed · Phase 2 · Epizyme, Inc.
Ages 18 and over
https://clinicaltrials.gov/study/NCT02601950
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Chordoma
Chordoma is a rare slow-growing bone tumour that arises from remnants of the notochord, the embryonic structure that helps form the spine. It most often develops at the base of the skull or in the lower spine and tailbone, and can press on nearby nerves and tissues. Treatment usually involves surgery and radiation therapy, and researchers are studying targeted therapies.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Chordoma?
Chordoma is a rare slow-growing bone tumour that arises from remnants of the notochord, the embryonic structure that helps form the spine. It most often develops at the base of the skull or in the lower spine and tailbone, and can press on nearby nerves and tissues. Treatment usually involves surgery and radiation therapy, and researchers are studying targeted therapies.
How many clinical trials are available for Chordoma?
RareWays currently indexes 50 clinical trials for Chordoma, of which 6 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Chordoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Chordoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.